glp-1 approved for weight loss Compare Options | Ozempic v Mounjaro | WeightWatchers GLP-1 Agonists: A Comprehensive Overview

The medication carries a black box warning about thyroid C-cell tumors, but no human cases have been definitively linked to GLP-1 agonist use

In the years since coming to market, GLP-1RA therapeutics development and adoption has exploded, with six now approved by the FDA

Adults are also more likely to have obesity-related comorbidities such as type 2 diabetes and cardiovascular diseases, where GLP-1 therapies provide additional benefits, increasing their use

Because GLP-1s stop working when not taken, weight loss maintenance is another category of interest

Recent trends in the alcohol industry show a noticeable slowdown in sales, particularly in regions where the use of GLP-1 drugs is most prevalent